期刊名称：VIRAL IMMUNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
This peer-reviewed journal centralizes the growing body of research in viral immunology, with papers on clinical, veterinary, and laboratory research. Topics covered include human and animal viral immunology; research and development of viral vaccines, including field trials; immunological characterization of viral components; virus-based immunological diseases, including autoimmune syndromes; viral pathogenesis; viral diagnostics; tumor and cancer immunology with virus as the primary factor; and viral immunology methods. Indexed in Index Medicus, Medline, Current Contents/Life Sciences, EMBASE, Excerpta Medica, Cambridge Scientific Abstracts, Science Citation Index-Expanded, Science Citation Index, Research Alert, Tropical Disease Bulletin, and the Center for Disease Control and Prevention's Laboratory Performance Evaluation. |
 |
Instructions to Authors
Your paper will undergo peer review. You will be advised whether it is acceptable and if so whether revisions have been recommended.
Manuscripts must be submitted online using the following url:
http://mc.manuscriptcentral.com/viral
Please read all the instructions to authors before submitting.
The Journal will publish both full and short communications. Full communications should be prepared as described below; short communications do not need compartmentalization and should be limited to a maximum of two tables or two figures, or one of each. Contributions to the Journal are published at no charge to the author. Once a paper has been accepted for publication, it cannot be withdrawn. Authors will be allowed to indicate one reviewer who should be excluded from review of their manuscript.
Manuscript Submission and Copyright Agreement Form
The Copyright Agreement form (available from web site at transfer_of_copyright.pdf.) should be submitted once your paper has been accepted for publication. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Upon acceptance of your paper, please fax the Copyright Agreement form to 914-740-2108.
PREPARATION OF MANUSCRIPT
Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include artwork within the text document. Figures and tables should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Please see the Tables and Illustrations section for futher details on art submission.
TABLES AND ILLUSTRATIONS
Electronic submission of art MUST follow these guidelines:
- Do not include any illustrations as part of your text file.
- Do not prepare any figures in Word as they are not workable.
- Line illustrations must be submitted at 1200 DPI.
- Halftones and color photos should be submitted at 300 DPI.
- Please submit only TIFF or EPS files.
- Tables should be submitted in Word
- Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted to CYMK, and some slight color variation may occur.
- When naming your figure files, please label them with the first author’s last name followed by Figure 1., Figure 2,, etc. Label figures and tables inside the files in addition to naming the file with the figure or table number. (i.e.: When figures or table files are opened, the figure or table number should appear inside the file.)
- Do NOT submit PowerPoint or Excel files. Adobe is the software of choice.
1) Tables should be typed double spaced, one to a page and are placed after the references. 2) Legends for tables go above the table. Capitalize TABLE 1., etc. with Arabic numerals. 3) Capitalize FIGURE 1., etc. and set it to the left of the title on the same line. Remember, each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Do not repeat information that is given in the text, and do not make a table for data which can be given in the text in one or two sentences.
FOOTNOTES. Footnotes should be typed double spaced on a separate page. They should be used only when essential.
ACKNOWLEDGMENTS. Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the LITERATURE CITED section.
Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
LITERATURE CITED. (1) References should be listed in alphabetical order but are cited in the text by number in parentheses. (2) List all the authors, inverting the name of the first one only. (3) The order of the other elements is: year, title of paper, journal, volume, and inclusive page numbers. Please be certain all reference citations are accurate, as we do not check them. For a book, the order is: authors, year, chapter title, inclusive pages, editor(s) name(s), book title, publisher, city of publication. Papers that are in preparation or submitted (but not yet accepted) should be mentioned in parentheses in the text; they should not be included as LITERATURE CITED.
Please upload individual files of all manuscript material – do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
PERMISSIONS. The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher (not the author or editor) of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, the first footnote of a reprinted table, or the last sentence of the legend of a reprinted figure, should read "reprinted by permission from Ref. (00)" and list appropriate reference number.
REPRINTS. Be sure to type the complete name and address to which reprint requests should be directed. (See general typing instructions.) When the Editor has sent your manuscript to the publisher, you will receive a reprint order form which must be returned in FIVE DAYS.
PUBLISHER.The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, 3rd Floor, New Rochelle, New York 10801-5215. Telephone: (914) 740-2100; fax: (914) 740-2101; E-mail: info@liebertpub.com internet: www.liebertpub.com
Editorial Board
Editor-in-Chief
David Woodland
Trudeau Institute
154 Algonquin Ave
Saranac Lake, NY 12983
Tel: (518) 891-3080
Fax: (518) 891-5126
dwoodland@trudeauinstitute.org
Editorial Board
Ann M. Arvin, Stanford University School of Medicine
Jack R. Bennink, National Institutes of Health
Thomas J. Braciale, Beirne Carter Center
Michel Brahic, Institut Pasteur
Michael J. Buchmeier, University of California
Iain Campbell, University of Sydney
Louisa Chapman, Centers for Disease Control and Prevention
Bruce Chesebro, Rocky Mountain Laboratories - NIH
Hildegund C.J. Ertl, Wistar Institute
John Fazakerley, University of Edinburgh
Robert W. Finberg, University of Massachusetts Medical School
Howard Fox, Scripps Research Institute
Harry B. Greenberg, Stanford University School of Medicine
Young S. Hahn, University of Virginia Health Sciences Center
Tracy Hussell, Imperial College London
Steven Jacobson, National Institutes of Health
Krister Kristensson, Karolinska Institut
Michael D. Lairmore, The Ohio State University
Beth Levine, University of Texas Southwestern Medical Center
W. Ian Lipkin, Columbia University
Margaret A. Liu, Transgene
Aron E. Lukacher, Emory University School of Medicine
Laura Manuelidis, Yale University School of Medicine
Stephen D. Miller, Northwestern University
Stephen S. Morse, Columbia University
Daniel Muller, University Wisconsin-Madison
Philip Murphy, National Institutes of Health
Tony Nash, University of Edinburgh
Jay A. Nelson, Oregon Health Sciences University
Peter J. Openshaw, Imperial College School of Medicine
Hugh V. Perry, University of Southampton
Glenn F. Rall, Fox Chase Cancer Center
Ian Ramshaw, Australian National University
Matthias J. Reddehase, Johannes Gutenberg University
Carol Shoshkes Reiss, New York University
Alan Rickinson, University of Birmingham
Stanley Riddell, Fred Hutchinson Cancer Center
Moses Rodriguez, Mayo Clinic
Barry T. Rouse, University of Tennessee
Geoffrey R. Shellam, University of Western Australia
Robert H. Silverman, Cleveland Clinic Foundation
Peter Staeheli, University of Freiberg
Stephen Stohlman, University of Southern California
Hidemi Takahashi, Nippon Medical School
Herbert W. Virgin IV, Washington University School of Medicine
J. Lindsay Whitton, Scripps Research Institute
Bryan R. G. Williams, Cleveland Clinic Foundation
William S. Wold, St. Louis University
Susan Zolla-Pazner, New York University Medical Center
| 
